Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MAPK-interacting and spindle-stabilizing protein-like (MAPK1IP1L) is a protein encoded by the MAPK1IP1L gene in humans. The gene resides on chromosome 14. Based on gene annotation and naming, this protein may be associated with spindle stability during mitosis and interact with mitogen-activated protein kinase 1 pathways, potentially influencing cell proliferation. However, there is currently no direct experimental evidence for its molecular function, biological process, or cellular localization in humans. Limited database associations suggest a possible link to TFE3-rearranged renal cell carcinoma and progressive familial heart block, but the specific pathological role remains unclear. MAPK1IP1L is not recognized or classified as a receptor, enzyme, transporter, ion channel, transcription factor, or biomarker, and it is not targeted by approved therapeutic agents
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MAPK-interacting and spindle-stabilizing protein-like (MAPK1IP1L).